These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
203 related items for PubMed ID: 17185751
1. Neuropilin-1 and neuropilin-2 enhance VEGF121 stimulated signal transduction by the VEGFR-2 receptor. Shraga-Heled N, Kessler O, Prahst C, Kroll J, Augustin H, Neufeld G. FASEB J; 2007 Mar; 21(3):915-26. PubMed ID: 17185751 [Abstract] [Full Text] [Related]
2. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1. Starzec A, Vassy R, Martin A, Lecouvey M, Di Benedetto M, Crépin M, Perret GY. Life Sci; 2006 Nov 17; 79(25):2370-81. PubMed ID: 16959272 [Abstract] [Full Text] [Related]
4. Expression of VEGF, semaphorin SEMA3F, and their common receptors neuropilins NP1 and NP2 in preinvasive bronchial lesions, lung tumours, and cell lines. Lantuéjoul S, Constantin B, Drabkin H, Brambilla C, Roche J, Brambilla E. J Pathol; 2003 Jul 17; 200(3):336-47. PubMed ID: 12845630 [Abstract] [Full Text] [Related]
5. The interaction of Neuropilin-1 and Neuropilin-2 with tyrosine-kinase receptors for VEGF. Neufeld G, Kessler O, Herzog Y. Adv Exp Med Biol; 2002 Jul 17; 515():81-90. PubMed ID: 12613545 [Abstract] [Full Text] [Related]
6. Neuropilin-1 forms complexes with vascular endothelial growth factor receptor-2 during megakaryocytic differentiation of UT-7/TPO cells. Ohsaka A, Hirota-Komatsu S, Shibata M, Komatsu N. Biochem Biophys Res Commun; 2009 Dec 25; 390(4):1171-6. PubMed ID: 19857463 [Abstract] [Full Text] [Related]
7. Expression of VEGFR-2 on HaCaT cells is regulated by VEGF and plays an active role in mediating VEGF induced effects. Yang XH, Man XY, Cai SQ, Yao YG, Bu ZY, Zheng M. Biochem Biophys Res Commun; 2006 Oct 13; 349(1):31-8. PubMed ID: 16930552 [Abstract] [Full Text] [Related]
8. Inhibitory activity of ranibizumab, sorafenib, and pazopanib on light-induced overexpression of platelet-derived growth factor and vascular endothelial growth factor A and the vascular endothelial growth factor A receptors 1 and 2 and neuropilin 1 and 2. Kernt M, Thiele S, Neubauer AS, Koenig S, Hirneiss C, Haritoglou C, Ulbig MW, Kampik A. Retina; 2012 Sep 13; 32(8):1652-63. PubMed ID: 22466477 [Abstract] [Full Text] [Related]
9. Orf virus VEGF-E NZ2 promotes paracellular NRP-1/VEGFR-2 coreceptor assembly via the peptide RPPR. Cébe-Suarez S, Grünewald FS, Jaussi R, Li X, Claesson-Welsh L, Spillmann D, Mercer AA, Prota AE, Ballmer-Hofer K. FASEB J; 2008 Aug 13; 22(8):3078-86. PubMed ID: 18467594 [Abstract] [Full Text] [Related]
10. Vascular endothelial growth factor (VEGF)-A165b is a weak in vitro agonist for VEGF receptor-2 due to lack of coreceptor binding and deficient regulation of kinase activity. Kawamura H, Li X, Harper SJ, Bates DO, Claesson-Welsh L. Cancer Res; 2008 Jun 15; 68(12):4683-92. PubMed ID: 18559514 [Abstract] [Full Text] [Related]
11. Immunolocalization and expression of vascular endothelial growth factor receptors (VEGFRs) and neuropilins (NRPs) on keratinocytes in human epidermis. Man XY, Yang XH, Cai SQ, Yao YG, Zheng M. Mol Med; 2006 Jun 15; 12(7-8):127-36. PubMed ID: 17088944 [Abstract] [Full Text] [Related]
12. Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells. Hsieh SH, Ying NW, Wu MH, Chiang WF, Hsu CL, Wong TY, Jin YT, Hong TM, Chen YL. Oncogene; 2008 Jun 12; 27(26):3746-53. PubMed ID: 18223683 [Abstract] [Full Text] [Related]
13. Neuropilins in physiological and pathological angiogenesis. Staton CA, Kumar I, Reed MW, Brown NJ. J Pathol; 2007 Jul 12; 212(3):237-48. PubMed ID: 17503412 [Abstract] [Full Text] [Related]
15. Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. Kärpänen T, Heckman CA, Keskitalo S, Jeltsch M, Ollila H, Neufeld G, Tamagnone L, Alitalo K. FASEB J; 2006 Jul 24; 20(9):1462-72. PubMed ID: 16816121 [Abstract] [Full Text] [Related]
16. [Advances of research on vascular endothelial growth factor receptors in epidermal neoplasm]. YANG P, ZHENG M. Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Jul 24; 38(4):422-6. PubMed ID: 19693983 [Abstract] [Full Text] [Related]
17. Differential expression of vascular endothelial growth factor (VEGF), endocrine gland derived-VEGF, and VEGF receptors in human placentas from normal and preeclamptic pregnancies. Chung JY, Song Y, Wang Y, Magness RR, Zheng J. J Clin Endocrinol Metab; 2004 May 24; 89(5):2484-90. PubMed ID: 15126581 [Abstract] [Full Text] [Related]
18. Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis. Guttmann-Raviv N, Shraga-Heled N, Varshavsky A, Guimaraes-Sternberg C, Kessler O, Neufeld G. J Biol Chem; 2007 Sep 07; 282(36):26294-305. PubMed ID: 17569671 [Abstract] [Full Text] [Related]
19. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation. Pala L, Cresci B, Manuelli C, Maggi E, Yamaguchi YF, Cappugi P, Rotella CM, Giannini S. Microvasc Res; 2005 Nov 07; 70(3):179-88. PubMed ID: 16271941 [Abstract] [Full Text] [Related]
20. Parapoxvirus of red deer in New Zealand encodes a variant of viral vascular endothelial growth factor. Ueda N, Inder MK, Wise LM, Fleming SB, Mercer AA. Virus Res; 2007 Mar 07; 124(1-2):50-8. PubMed ID: 17109982 [Abstract] [Full Text] [Related] Page: [Next] [New Search]